Clinical Trial

Evaluate Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of BCD-261 After Single Subcutaneous Injection in Healthy Chinese Volunteers

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The goal of this study is to evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of BCD-261 after Single Subcutaneous Injection in Healthy Chinese Volunteers
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-06-27
Trial Details
NCT Number NCT07535775
Lead Sponsor SPH-BIOCAD (HK) Limited
Conditions Healthy Adult Participants
Enrollment 48 participants
Start Date 2026-05-11
Primary Completion 2026-10-10 (estimated)
Study Completion 2027-03-20 (estimated)
Updated on ClinicalTrials.gov 2026-06-26